Correlation Between Viridian Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Viridian Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Viridian Therapeutics and Terns Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Viridian and Terns is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.15 times more return on investment than Terns Pharmaceuticals. However, Viridian Therapeutics is 1.15 times more volatile than Terns Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 2,328 in Viridian Therapeutics on August 29, 2024 and sell it today you would lose (137.00) from holding Viridian Therapeutics or give up 5.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Viridian Therapeutics |
| Terns Pharmaceuticals |
Viridian Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Viridian Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |